Katrina Walker

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Radiation Induced

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Martin F Kaiser, Andrew Hall, Katrina Walker, Amy Sherborne, Ruth M De Tute, Nicola Newnham, Sadie Roberts, Emma Ingleson, Kristian M Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Richard S Houlston, Graham H Jackson, Curly T C M Morris, Guy Pratt, Roger G Owen, Mark T Drayson, Sarah R Brown, Matthew W Jenner
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Katrina Walker, Samantha Hinsley, Rachel Phillip, Jamie B Oughton, Geraldine Murden, Anthony J Chalmers, Corinne Faivre-Finn, Alastair P Greystoke, Sarah R Brown, null null
Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE. JCO precision oncology 6 (2022)
Samantha Hinsley, Katrina Walker, Debbie Sherratt, Lucy Bailey, Sadie Reed, Louise Flanagan, Sophie McKee, Fiona Brudenell Straw, Bryony Dawkins, David Meads, Holger W Auner, Martin F Kaiser, Mark Cook, Sarah Brown, Gordon Cook, null null
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor. Trials 21 (1) (2020)